MY102920A - Hepatitis b virus vaccine. - Google Patents

Hepatitis b virus vaccine.

Info

Publication number
MY102920A
MY102920A MYPI87002209A MYPI19872209A MY102920A MY 102920 A MY102920 A MY 102920A MY PI87002209 A MYPI87002209 A MY PI87002209A MY PI19872209 A MYPI19872209 A MY PI19872209A MY 102920 A MY102920 A MY 102920A
Authority
MY
Malaysia
Prior art keywords
hepatitis
virus vaccine
yeast
hbsag
gene
Prior art date
Application number
MYPI87002209A
Other languages
English (en)
Inventor
Wilde Michel De
Teresa Cabezon
Nigel Harford
Original Assignee
Smithkline Biologicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Biologicals filed Critical Smithkline Biologicals
Publication of MY102920A publication Critical patent/MY102920A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI87002209A 1982-09-08 1987-09-29 Hepatitis b virus vaccine. MY102920A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41578982A 1982-09-08 1982-09-08
EP83870090A EP0106828B1 (fr) 1982-09-08 1983-09-06 Molécules d'ADN recombinantes codant pour l'antigène de surface de l'hépatite B, leur préparation et vaccins qui en dérivent

Publications (1)

Publication Number Publication Date
MY102920A true MY102920A (en) 1993-03-31

Family

ID=23647197

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002209A MY102920A (en) 1982-09-08 1987-09-29 Hepatitis b virus vaccine.

Country Status (21)

Country Link
EP (1) EP0106828B1 (ref)
JP (5) JPS5971694A (ref)
KR (1) KR840006014A (ref)
AT (1) ATE91718T1 (ref)
AU (4) AU584580B2 (ref)
CA (1) CA1222707A (ref)
CY (1) CY1932A (ref)
DE (1) DE3382704T2 (ref)
DK (1) DK406483A (ref)
ES (4) ES525439A0 (ref)
FI (1) FI833205L (ref)
GR (1) GR78982B (ref)
HU (1) HU196625B (ref)
IE (1) IE60387B1 (ref)
IL (1) IL69202A (ref)
MA (1) MA19895A1 (ref)
MY (1) MY102920A (ref)
NO (1) NO833198L (ref)
NZ (1) NZ204952A (ref)
PT (1) PT77265B (ref)
ZA (1) ZA836658B (ref)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5931799A (ja) * 1982-08-16 1984-02-20 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えプラスミド
JPS5936699A (ja) * 1982-08-20 1984-02-28 Chemo Sero Therapeut Res Inst シヤトルベクタ−
WO1986007384A1 (fr) * 1985-06-03 1986-12-18 Takeda Chemical Industries, Ltd. Procede de preparation de l'antigene p31 de surface du virus de l'hepatite b
WO1986003411A1 (fr) * 1984-12-12 1986-06-19 Takeda Chemical Industries, Ltd. Procede de preparation d'une nouvelle proteine
WO1986001534A1 (fr) * 1984-09-04 1986-03-13 Takeda Chemical Industries, Ltd. Adn recombinant et son utilisation
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
EP0211767B1 (en) * 1985-08-05 1991-03-06 Merck & Co. Inc. Method for increasing recombinant protein production in yeast species of the genus saccharomyces
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
EP0278940A3 (en) * 1987-01-30 1988-12-07 Smithkline Biologicals S.A. Hepatitis b virus surface antigens and hybrid antigens containing them
ATE93891T1 (de) * 1987-03-09 1993-09-15 Merck & Co Inc Reinigung von rekombiniertem hepatitis-boberfl|chen-antigen.
NZ229260A (en) * 1988-06-03 1994-02-25 Merck & Co Inc Hepatitis b virus, expression cassette for pre-s domain, host cells and
US4962656A (en) * 1989-06-30 1990-10-16 The United States Of America As Represented By The United States Department Of Energy Control and monitoring method and system for electromagnetic forming process
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
TW340132B (en) * 1994-10-20 1998-09-11 Ibm Structure for use as an electrical interconnection means and process for preparing the same
JP4028850B2 (ja) * 2004-02-04 2007-12-26 株式会社名機製作所 ディスク基板の成形用金型

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171727B1 (da) * 1978-12-22 1997-04-14 Biogen Inc Rekombinante hepatitis B virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenspecifikke polypeptider, DNA-sekvenser kodende for HBV-antigenspecifikke polypeptider, metoder til påvisning af hepatitis B virus-antistoffer, metoder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider og midler til påvisning af HBV-infektion
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
GR76274B (ref) * 1981-08-04 1984-08-04 Univ California
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides

Also Published As

Publication number Publication date
FI833205A7 (fi) 1984-03-09
AU9001491A (en) 1992-02-27
KR840006014A (ko) 1984-11-21
FI833205A0 (fi) 1983-09-07
ES532731A0 (es) 1985-11-01
NZ204952A (en) 1986-05-09
ES532732A0 (es) 1985-10-16
JPH02116A (ja) 1990-01-05
JP2522825B2 (ja) 1996-08-07
DK406483D0 (da) 1983-09-07
ES8600939A1 (es) 1985-10-16
NO833198L (no) 1984-03-09
HK1004570A1 (en) 1998-11-27
IE60387B1 (en) 1994-07-13
CA1222707A (en) 1987-06-09
AU1569288A (en) 1988-07-28
EP0106828B1 (fr) 1993-07-21
MA19895A1 (fr) 1984-04-01
HU196625B (en) 1988-12-28
DK406483A (da) 1984-03-09
CY1932A (en) 1983-09-06
FI833205L (fi) 1984-03-09
ES532730A0 (es) 1985-10-16
AU3131889A (en) 1989-07-20
ES8600938A1 (es) 1985-10-16
JPH02231084A (ja) 1990-09-13
ATE91718T1 (de) 1993-08-15
EP0106828A3 (en) 1985-11-21
ZA836658B (en) 1984-06-27
GR78982B (ref) 1984-10-02
AU1675083A (en) 1984-03-15
IL69202A (en) 1991-08-16
JPH02464A (ja) 1990-01-05
ES8602120A1 (es) 1985-11-01
PT77265A (en) 1983-09-01
JP2702899B2 (ja) 1998-01-26
ES8506350A1 (es) 1985-07-01
JPS5971694A (ja) 1984-04-23
ES525439A0 (es) 1985-07-01
JPH08317796A (ja) 1996-12-03
PT77265B (en) 1986-02-04
IE832099L (en) 1984-03-08
DE3382704D1 (de) 1993-08-26
EP0106828A2 (fr) 1984-04-25
DE3382704T2 (de) 1994-02-10
AU584580B2 (en) 1989-06-01

Similar Documents

Publication Publication Date Title
IE800991L (en) HBs Ag GENE AND PRODUCT
MY117686A (en) Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
DK577783D0 (da) Vektor for udtrykkelse af et dna-segment i gaer
ZA836658B (en) Hepatitis b virus vaccine
DE3280284D1 (de) Herstellung von oberflaechen-hepatitis-b-antigen in hefe.
BG60107B2 (bg) Метод за получаване на еукариотен полипептид
GR3024144T3 (en) Recombinant herpes simplex viruses vaccines and methods
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
EP0677114A4 (en) RECOMBINED PIGROCK VIRUS.
IL69423A0 (en) Recombinant plasmid inserted with hepatitis b virus gene,yeast transformed with said recombinant plasmid and production of hepatitis b virus surface antigen
EP0101617A3 (en) Recombinant dna containing a hepatitis b virus gene, mammalian cells transformed with the cloned viral dna, and production of hepatitis b virus proteins
EP0151079A3 (en) Vaccine against epstein-barr virus
EP0037723A3 (en) Expression of hormone genomic clones
IL90035A (en) Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
EP0105149A3 (en) Recombinant plasmid containing hepatitis b virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis b virus surface antigen
EP0216564A3 (en) Infectious recombinant virus, vaccines containing said virus for feline leukemia, and methods for the production thereof
ES8504254A1 (es) Procedimiento para obtener un polipeptido
EP0068719A3 (en) Deoxyribonucleic acids, their production and use
EP0152030A3 (en) Adult t cell leukemia virus antigen polypeptide
JO1885B1 (en) A method for purifying surface serum for viral hepatitis B, consisting of Bryce 2 peptide
Lapin Epidemiology of leukemia among baboons of Sukhumi monkey colony
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ
RU1651555C (ru) Рекомбинантна плазмидна ДНК р7,5С, кодирующа антиген вируса гепатита В, и способ ее конструировани
AU8277582A (en) Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them
Lunin et al. Cloning and expression of the gene coding the surface antigen of hepatitis B virus(HBsAg) in Escherichia coli.